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Abstract 
 
Introduction: Recent improvements in cancer treatment have not only increased 
cancer survivorship but also peoples’ ability to work during and following treatment. However, 
the impact that both diagnosis and treatment has on cancer survivors’ ability to fully engage in 
paid work is not yet entirely understood. This study aims to explore the role of symptoms, work 
adjustments and cancer disclosure to supervisors and co-workers on working during primary 
cancer treatment and return to work following treatment. 
Method: 328 cancer survivors responded to a 33 item questionnaire that assessed cancer-specific 
variables e.g. type and treatment, symptoms experienced during and following treatment, 
disclosure of cancer and adjustments and supports available at work. Multivariate logistic 
regressions were run to determine the association of symptoms, disclosure and work adjustments 
and working during treatment and returning to work following treatment.  
Results: The findings indicate that opportunities to work flexibly (OR=2.43, CI 1.21–4.02), 
disclosure to colleagues (OR=3.03, CI 1.28–8.19), difficulties managing fatigue (OR=2.08, CI 
1.22–3.85), and paid time off to attend all medical appointments (OR=.4, CI .30–.87) were 
associated with continuing to work during treatment. Correlates of return to work included 
difficulties managing fatigue (OR=1.49, CI 1.42–6.18), managing the stress of cancer (OR=2.80, 
1.05–5.34), managing physical changes associated with cancer (OR=.46, CI .13–.95), received 
advice from their doctor about work (OR=1.47, CI 1.09–2.84) and return to work meeting with 
employer (OR 1.99, 1.2–5.09).  
Conclusions: This study highlights the importance of symptom management in cancer survivors 
who work and the potential impact of workplace adjustments on the ability of cancer survivors to 
navigate in the world of work. 
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Introduction It is estimated that 90,000 new cases of cancer are diagnosed in people of working 
age each year in the UK alone [1]; over a million cases in the US [2]. Advances in drug treatment 
now mean that cancer is shedding its status as a terminal illness and is increasingly perceived as 
a chronic disease requiring treatment, lifestyle change and monitoring [3]. Recent reports 
suggest that adult survivorship is on the increase [4], most notably within colorectal, breast, 
testicular cancer groups [2]. As a result, this means that more people continue to resume their 
everyday life during or following treatment. This includes remaining in or returning to 
employment. The effects of cancer and its treatment are by no means uniform [5], which currently 
make it difficult to generalise about the impact cancer and its treatment has on work. However, it 
is likely that some commonalities may be seen between cancer survivors to help formulate 
guidance for those working with or returning to work following cancer. 
 
The employment status of cancer patients and survivors has important implications for 
society and the labour market, for organisations, and for the individuals and their economic, 
social and psychological health. Data suggest that approximately 62–84% of cancer patients 
return to work following treatment, with similar patterns found across European countries, 
Canada and the United States [5–8]. Despite this growing body of research in the area of cancer 
and work, very little is known about the specific psychosocial factors affecting continuance and 
return to work [9]. For example, there is limited information to inform cancer survivors about the 
possible impact of cancer, its treatment and long term side effects on work. There is also limited 
information on the work adjustments that can be made available and how to access them; when 
and how to manage exit from work and return to work; or supporting cancer survivors in 
managing work relationships. It is not surprising that many people with cancer remaining at work 
throughout treatment or returning to work, experience difficulties in managing their work due 
coping with physical changes, emotional pressures and fatigue associated with cancer and its 
treatment without adequate work-related support [3]. With the increase in cancer survivorship 
there is a need to address the quality of working life of cancer survivors. Healthcare and 
rehabilitation professionals could play a pivotal role in supporting this aspect of cancer 
survivorship. Effects of cancer, its treatment and ability to work 
 
Research in the area of cancer and work has typically focused on employability statistics, adopting 
a health economic perspective (for example [3,10]), and more recently, the employment pathways 
of cancer survivors [7]. In their study, Short and colleagues identified that whilst one in five 
survivors reported cancer-related disabilities at follow-up, half continued to work. Furthermore, 
13% of all survivors had withdrawn from work for cancer-related reasons within four years. The 
effects of cancer and its treatment that are likely to impact on an individuals’ ability to work are 
many, and may present in combination. These include physical factors related to the disease (e.g. 
disfigurement or pain following surgery, [10, 11]), fatigue [12], cognitive functioning [13, 14]; and 
need for transportation [8, 15]. Importantly, many of these side effects and consequences of 
cancer and its treatment may be more enduring and may last for many years post treatment. 
Many of the physical and cognitive limitations are also seen in other chronic illnesses [16, 17], and 
there is an opportunity to draw from the wider sphere of rehabilitation to provide a useful steer 
for cancer survivors and for practitioners in supporting them through their treatment and 
rehabilitation. 
 
Whilst it is widely recognised that work adjustments fall into three broad categories: Modi- fied 
physical load (e.g. reduced weights in manual role or provision of supportive technologies), skill 
discretion (e.g. reorganisation of work) and time discretion (e.g. arranging home working or 
flexible working), a limited number of studies have examined the role of work 
adjustments specifically for cancer patients. Evidence suggests that, when an option, cancer 
survivors rely heavily on adjustments in time discretion, working reduced hours during and 
following treatment [18]. Whether adjustments to working time are a readily accessible ‘default’ 
option or an effective and appropriate adjustment remains to be understood. However, it does 
suggest that cancer survivors are not using the full complement of adjustments available to 
them. Drawing from the wider rehabilitation literature, the benefits of work adjustments can 
include improved illness management, psychological well-being and financial 
stability/independence [19]. 
 
Currently, it is not fully understood how cancer patients perceive their ability to work or the 
adjustments that are required to facilitate work during and following treatment. Studies that have 
attempted to address these concerns continue to be hampered by small sample sizes and a lack of 
control for cancer site, and in-depth studies have been largely restricted to case study and 
qualitative research [5]. There is need to explore the prevalence of these issues in larger surveys 
and longitudinal designs to develop best practice and influence policy in cancer rehabilitation. In 
practice, health care practitioners make inferences based on the medical literature (e.g. the 
impact of treatment and its side-effects); information gleaned from learning through experience, 
or information obtained from cancer support organisations (for example; American Cancer 
Society or CancerBACUP). This highlights three problems: first, there is a lack of evidence-based 
research in cancer and work to inform reliable and valid guidance and by implication, an absence 
of advice [6]; second, it requires health care professionals and cancer patients to make conceptual 
leaps between side-effects and work limitations or disabilities; third, the support information 
available is largely restricted to guidance on the legal rights of patients or general work 
rehabilitation practices (that may not be applicable to cancer patients). 
 
Whilst advances are being made to better understand the consequences of cancer on work, there 
is need to gain a better understanding of the work limitations experienced by cancer survivors 
during and following treatment, and thework adjustments cancer survivors use to better manage 
their work. Further, there is need to continue to expand our understanding of 
whether employment pathways of cancer survivors differ across countries due to different 
employment contexts. This study aims to: 
 
(i) identify the symptoms, disclosure and work adjustments associated with working 
during treatment across a range of cancer groups. 
 
(ii) identify the symptoms, disclosure and work adjustments associated with returning to 
work following treatment across a range of cancer groups. 
Method 
Participants 
This was a cross-sectional study. 800 paper questionnaires were distributed to users 
registered with a UK-based cancer charity. An online version of the questionnaire was also made 
available on the charity’s website. To allow for a breadth of response and the exploration of 
differential patterns in work, both cancer survivors and people with cancer were invited to 
complete the questionnaire. 210 paper questionnaires were returned and a further 118 were 
completed online (N=328). We were not able to compare the demographic and cancer-specific 
details of responders and non-responders. Respondents were predominantly female (76.5%) and 
the respondents ranged from 18 to 68 years in age (average 50.37 years, SD=10.08). In total, 45 
different forms of cancer were identified and grouped into eight broad categories of diagnosis 
following advice from oncology specialists and drawing from previous research [7]. Full details of 
cancer types and treatment can be seen in Table 1. Respondents worked across job categories. A 
total of 199 different job titles were manually coded using the Standard Occupational 
Classification framework [22]. An overview is provided in Table 2. In terms of sizes of 
organisations represented, 6% of respondents were self-employed, 24% worked in small 
organisations (organisations employing between 2–49 employees), 29% worked in medium sized 
organisations (between 50–1000 employees) and 34% worked in large organisations (more than 
1000 employees) at the time of their diagnosis. 
Measures 
The 33 item questionnaire included five sections: (i) Demographics including age, gender 
and occupation; (ii) Cancer-specific information which asked respondents to provide 
information about their cancer type, duration and treatment regime; (iii) Symptoms associated 
with cancer and its treatment included a series of one-item questions developed from the 
literature. Commonly reported side-effects of cancer and its’ treatment were listed and can be 
seen in Table 4. These symptoms were preceded with the statement ‘which of the following side 
effects were difficult to manage during and following your cancer treatment?’ Response were 
reported on a yes or no dichotomy; iv) Disclosure of cancer at work. Single-item measures of 
disclosure to line manager and to colleagues were included. Disclosure was measured on a four-
point response scale of yes, no, can’t remember and not applicable. For the purposes of 
analysis, this was recoded into a dichotomous variable (where 1 = yes); and (v) Work supports 
and adjustments sought and received (e.g. adjustment of physical environment, flexible/ 
alternative work arrangements). Items were developed from research within the wider fields of 
chronic illness and return to work [15–17] and included issues relating to rehabilitation policy 
(e.g. participation in a return to work interview) and work adjustments related to time 
discretion and physical load. Items were preceded with the statement ‘Has your organisation 
offered you the following policies or services?’ Work adjustment items were measured on a 
dichotomous response scale (yes/no). An open-text box at the questionnaire also invited 
respondents to note any further information of interest relating to their experience of cancer 
survivorship and work. The symptoms, disclosure and work adjustments reported by the 
respondents are summarised in Table 4. The questionnaire was developed by the researchers as 
there were no measures available that could readily be incorporated to measure aspects of cancer 
survivorship and work. The questionnaire was piloted with a sample of cancer patients prior to 
distribution and took approximately 25 min to complete. The questionnaire can be provided by 
the authors. No significant differences were found on between paper-based and online completion 
on any measures. 
Analysis 
The factors associated with working during treatment and returning to work following 
treatment were calculated using univariate and multivariate logistic regression analyses (SPSS, 
version 10). In order to identify significant predictors of working during treatment (and thus 
simplify the relationships between a large number of variables), the data on each aspect of 
symptoms, disclosure and work adjustments, were separately entered into a univariate logistic 
regression analysis against the outcome variable of working during treatment. Those proving to 
be significant predictors at p < 0.1 level were then entered into multivariate stepwise logistic 
regression [23]. To identify the most parsimonious model of the data, the regression analysis was 
run a number of times, with the least significant variable removed from the model each time the 
regression was run until only a significant set of variables remained in the model. Parameter 
coefficients were monitored throughout this process to ensure important variables were not 
removed. The same procedure was followed against the outcome variable returning to work 
following treatment (Tables 5 and 6). 
Results 
An overview of cancer and treatments received by the sample are detailed in Table 1. The majority 
of the respondents were female (77%) and accordingly the highest reported cancer incidence was 
breast cancer (n=47). No significant differences were reported between breast cancer and other 
cancer groups on measures of symptoms or work adjustments and therefore further analysis is 
presented as a total group. Many of the respondents had received more than one type of 
treatment (28% received two types, 28% three types and 15% all treatments). No significant 
differences between age groups were found for working during treatment or returning to work 
following treatment. The work patterns of the group are presented in Table 3 which shows the 
reportedwork status (and transitions) before treatment, during treatment and 
following treatment. 
Factors relating to work during treatment 
30% of the sample continued to work during their treatment. Stepwise logistic regression identi-
 fied a parsimonious model of the data (÷ =25.7, df=3, p<.0001) that contained four 
significant correlates of working during treatment. The parsimonious model accurately classified 
71% of the cases, with 94% of those reporting not working during treatment and 15% reporting 
working during treatment accurately classified. In the parsimonious model those who were able 
to work flexibly (OR=2.43, CI 1.21–4.02) and who disclosed their cancer to their 
colleagues (OR=3.03, CI 1.28–8.19) were more likely to continue working during treatment. 
Working during treatment was also associated with difficulties managing fatigue (OR=2.08, CI 
1.22– 
Factors relating to return to work following treatment 
42.3% of the sample returned to work following their treatment. Stepwise logistic 
regression identified a parsimonious model of the data (÷ =33.0, df=3, p < .0001) that contained 
five significant correlates of returning to work following treatment. The parsimonious model 
accurately classified 69.8% of the cases, with 78% of those reporting not returning to work and 
60% reporting returning to work accurately classified. Correlates of return to work included 
difficulties managing fatigue (OR=1.49, CI 1.42–6.18), managing the stress of cancer 
(OR=2.80, 1.05–5.34), managing physical changes associated with cancer (OR=.46, CI .13–.95), 
received advice from their doctor about work (OR=1.47, CI 1.09–2.84) and return to work 
meeting with employer (OR 1.99, 1.2–5.09). 
Discussion 
The aim of this study was to further understanding of the experiences of work of cancer 
survivors. In line with previous research, the present findings indicate that working during 
treatment and returning to work is somewhat independent of cancer type and treatment type [12]. 
Whilst cancer and its treatment is known to impact on individuals psychological, cognitive and 
physical functioning [8,10–15], the actual risk that these present to work during, or following 
treatment, can not be determined because of the cross sectional design of this study. However, it 
is Interesting that the symptom of fatigue was associated with both working during treatment and 
returning to work. In contrast to previous research [12], these findings also suggest that people 
working during treatment are more likely to report higher levels of fatigue compared to those who 
cease to work during this time. Furthermore, those returning to work are also more likely to 
report higher levels of fatigue and stress, managing these symptoms compared to those who do 
not return to work. This suggests that managing both illness and work may increase poor 
physical and psychological health outcomes. This highlights a need to understand the interaction 
of work and the management of illness during treatment, as well as the impact of treatment on 
one’s ability to work. We suggest that compared with their actual functional limitations, there 
may be a mis-match of expectations versus ability to work. Some cancer survivors may 
perceive that their limitations are more significant than they are in reality, others may perceive 
that they can work harder than they can in reality. This could potentially have an impact on a 
person’s management of work and on their employers’ responsiveness to their needs. It is 
important that cancer survivors and their providers are aware of the impact the symptoms of 
cancer and its treatment and be encouraged to consider these in light of their current employment 
status and job role. However it is unclear at present how to detect those who experience these 
problems at work and those who do not. 
 
Previous research indicates that employer-made work adjustments that directly 
accommodate work limitations reported by employees managing various chronic illnesses, enable 
them to not only manage their work, but maintain employment [20]. The findings from the 
current study add some support to the use of work adjustment. In this study, those with cancer 
who continue to work during treatment were more likely to receive adjustments in the form of 
flexible work arrangements than those who did not continue to work during treatment. 
Furthermore, those individuals who reported returning to work following treatment were 
significantly more likely to report being offered a return to work meeting with their employer. 
Importantly, those reporting difficulties managing physical changes associated with their cancer 
were less likely to return to work than those who did not report physical changes. This, in 
combination with the absence of physical environment adjustments reported by respondents, 
suggests that further work adjustments may be required to accommodate survivors who 
experience physical changes. Given the unique set of symptoms cancer survivor’s report, future 
efforts need to investigate the effects of innovative accommodations. The current findings indicate 
that when work adjustments are tailored to meet the needs of those with cancer they are more 
likely to continue working or return to work. However, it is not known to what extent these work 
adjustments help to buffer the negative physical or psychological health outcomes such as fatigue 
and stress. Further longitudinal intervention-based studies are needed to delineate this 
relationship. 
 
Only half of the respondents in this study reported that they received advice and guidance 
from their General Practitioner or their workplace, and less than a quarter were offered 
information to help them manage work issues associated with their cancer. These findings are 
consistent with qualitative research studies conducted in North America [6, 21]. The incomplete 
and inconsistent provision of information about the impact of cancer and its treatment on the 
ability to work represents a substantial gap in our understanding. Importantly, those returning to 
work following treatment were more likely to report that they had received advice from their 
doctor than those who did not. This highlights the importance of developing a clear framework for 
guidance to allow healthcare professionals to provide cancer survivors with the necessary 
support. This study is not without limitations and there is need to interpret these findings with 
caution. The largest group of participants were breast cancer patients (44%) and this group far 
outweighed other cancer samples. Furthermore, participants were recruited through a support 
network. Not all cancer patients contact support organisations, and it may be that those who use 
such supports do so because they present higher levels of anxiety and illness-related distress. We 
were not able to compare the demographic and cancer-specific information of those who 
responded to the questionnaire and those who did not. Subsequently, our range of data collection 
may not be representative of all cancer survivors. Future research should aim to draw from 
clinical populations to sample the full spectrum of cancer survivors and followthe changes in 
employment status and the fluctuations of physical, social and psychological correlates during 
this time. Second, the full range of psychological, social and physical factors that may influence 
work were not examined here. Further research is required to develop a more detailed 
understanding of the psychological and social factors that actually predict continuance or return 
to work on the one hand, and the psychological consequences (e.g. anxiety and depression, illness 
distress, fear of illness reoccurrence) and the impact of workload, demands and support upon the 
well-being and functioning of cancer patients on the other. Whilst these limitations are 
recognised, the current study provides useful information about the experiences of cancer 
survivors managing work during and following treatment. Foremost, we hope that it sparks 
further research into this important but under-researched area. 
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